CORDIS Project
Funding breakdown and partner intelligence are Premium
Sign in and upgrade to Premium for EU contribution totals, consortium analytics, OpenAlex research context, and AI summaries. · 0 consortium intelligence fields visible of 1
Start free • Cancel anytime • 14-day refund guarantee
Meddrop GmbH has developed a novel drug delivery technology called TDA, which allows for targeted and non-invasive delivery of oxygen and medications through the skin. This technology aims to improve healing for chronic wounds and skin disorders.
TDA is an unprecedented drug delivery technology developed and patented by Meddrop GmbH.
This technology platform is capable of targeted delivery of active substances effectively and non-invasively. TDA transports a combination of both, oxygen and drugs through all skin layers.
These results and that of a series of wound treatments on diabetic wound patients prove that TDA has a huge potential in many areas, including the healing process on deep and chronic non-healing wounds as therapeutic moda…
Partner organizations (coordinator is shown above), with normalized type and CORDIS activity type. Guests see up to 4 partners.
Similar projects, consortium collaboration history, frequent partners, and OpenAlex research context.
Guests see up to 5 topics.
Guests see up to 5 keywords.
